Fluocinonide Information
What's inside Fluocinonide
Fluocinonide Active Ingredients: fluocinonide, details.| Fluocinonide Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Fluocinonide 0.05% | solution | topical | 100.0 milliliter(s) | OTC |
| Fluocinonide 0.05% | ointment | topical | 100.0 gram(s) | OTC |
| Fluocinonide 0.05% | cream | topical | 100.0 gram(s) | OTC |
| Fluocinonide 0.05% | gel | topical | 100.0 gram(s) | OTC |
| Fluocinonide - | powder | compounding | 100.0 gram(s) | OTC |
Recent Fluocinonide Side Effects
Posted by actjack18 over 5 years ago
I have been using Fluocinonide Cream USP, 0.05%. I have been using this to treat Psoriasis. I was wondering if this cream cau...
Posted by szczesniak over 5 years ago
I don't think it is exactly a side effect. I am using it for a red, itchy (tiny blisters) that seems to spread from one loca...
Fluocinonide in the News
Medicis Reports Fourth Quarter and Year End 2007 Financial Results - FOXBusiness
... LIDEX(R) (fluocinonide) Cream, 0.05%, VANOS(R) (fluocinonide) Cream, 0.1%, and ZIANA(R) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel, ...
Thu Feb 28 06:12:57 -0500 2008
Hair Loss Types with their Treatments - American Chronicle
Steroid injections, creams, and shampoos (such as clobetasol or fluocinonide) for the scalp have been used for many years. ...
Fri Feb 22 12:40:55 -0500 2008
Medicis to Present At Roth Capital Partners Conference - Primenewswire (press release)
all 6 news articles
Fri Feb 15 08:05:27 -0500 2008
Fluocinonide Chemical Information
fluocinonide - A synthetic glucocorticoid and derivative of fluocinolone acetonide with anti-inflammatory and antipruritic activity. Fluocinonide binds the glucocorticoid receptor, followed by translocation of the ligand-receptor complex to the nucleus and transcription activation of genes containing glucocorticoid-responsive elements. Lipocortin-1 is one factor induced by fluocinonide that interacts and inhibits cytosolic phospholipase 2 alpha, thereby preventing phospholipase translocation to the perinuclear membrane and subsequent release and conversion of arachidonic acid to inflammatory prostaglandins. In addition, MAPK phosphatase 1 is induced, thereby preventing the triggering of the MAPK cascade resulting in pro-inflammatory effects via Jun N-terminal kinase and c-Jun. Finally, fluocinonide binds to and inhibits nuclear factor kappa-B directly, resulting in inhibition of cyclooxygenase 2 transcription and subsequent prostaglandin synthesis.
Fluocinonide RSS Feed